Shionogi Inc. FDA Inspection Record
Shionogi Inc. is an FDA-inspected facility (FEI 3004530896) located in Alpharetta, GA, US. RegDataLab tracks 8 FDA inspections at this facility.
What FDA found at this site
- Latest inspection
- Feb 15, 2018: No Action Indicated (NAI)
- Inspections on record
- 8 (4 VAI, 4 NAI)
- Last OAI inspection
- None on record
- Warning letters
- None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
- Recalls as the recalling firm
- 9, latest May 24, 2017
- Import refusals
- 2
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Feb 15, 2018 | No Action Indicated (NAI) | No citations listed |
| Feb 2, 2015 | Voluntary Action Indicated (VAI) | SOPs not followed / documented (21 CFR 211.100(b)) Following/documenting laboratory controls (21 CFR 211.160(a)) Annual visual exams of drug products (21 CFR 211.170(b)) |
| May 16, 2013 | Voluntary Action Indicated (VAI) | No citations listed |
| Feb 8, 2012 | No Action Indicated (NAI) | Procedures not in writing, fully followed (21 CFR 211.22(d)) Determination not to conduct investigation of complaint (21 CFR 211.198(b)(3)) Written record of investigation incomplete (21 CFR 211.192) |
| Jul 9, 2010 | Voluntary Action Indicated (VAI) | Procedures not in writing, fully followed (21 CFR 211.22(d)) Investigations of discrepancies, failures (21 CFR 211.192) Approval and review of procedures (21 CFR 211.100(a)) Investigations made into any unexplained discrepancy (21 CFR 211.188(b)(12)) and 3 more |
| Jul 9, 2010 | No Action Indicated (NAI) | No citations listed |
| Jan 15, 2009 | Voluntary Action Indicated (VAI) | Procedures not in writing, fully followed (21 CFR 211.22(d)) SOPs not followed / documented (21 CFR 211.100(b)) Investigations of discrepancies, failures (21 CFR 211.192) Extent of discrepancy, failure investigations (21 CFR 211.192) and 4 more |
| Jan 15, 2009 | No Action Indicated (NAI) | No citations listed |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| May 24, 2017 | Class III | D-0219-2018 | Mefenamic Acid Capsules, USP, 250 mg, 30-count bottle, Rx only, Distributed by Prasco… Presence of foreign substance: The recall was initiated due to black particles being observed while performing routine post-release… |
| May 24, 2017 | Class III | D-0981-2017 | Mefenamic Acid, 250mg capsules, packaged in 30-count bottles, Rx Only, Distributed by… and 1 more product Failed Dissolution Specifications: Low dissolution results were obtained during stability testing |
| Jul 24, 2015 | Class III | D-1284-2015 | Nisoldipine Extended Release Tablets, 17 mg, packaged as a) Sular (nisoldipine) Extended… Failed Dissolution Specifications |
| Mar 8, 2012 | Class II | D-1398-2012 | Nisoldipine Extended Release Tablets, 17mg, 100 count bottle, Rx only, Manufactured for… Failed USP Dissolution Test Requirements: Out of Specification dissolution result at 18 month time point |
| Dec 23, 2010 | Class II | D-210-2011 | SULAR (nisoldipine) Extended Release 25.5 mg tablets, Rx only, 100 Tablets, Manufactured… and 1 more product The product failed dissolution testing at 8 hours at the 12-month stability testing time point. |
| Oct 28, 2010 | Class II | D-109-2011 | Twinject¿ (epinephrine injection, USP, 1:1000) auto-injector 0.3 mg, Two Pack, Rx only… and 2 more products Lack of Assurance of Sterility: Possibility exists a small number of sheaths covering the needle may have pinholes. |
| Sep 23, 2009 | Class III | D-031-2010 | Twinject ¿ 0.3 mg Auto-Injector (epinephrine injection, USP 1:1000), Rx only, Manufactured… Defective Delivery System; High Force-To-Fire values for the 12 month pull performance testing of Twinject 2008 annual stability units |
| Aug 3, 2009 | Class II | D-1889-2009 | Fenoglide (fenofibrate) tablets, 120 mg, 7 tablet Professional Sample bottle, Rx only… The product may lack efficacy due to the Out of Specification dissolution result at the 9-month stability pull point. |
| Jul 11, 2008 | Class II | D-042-2009 | Fenoglide (Fenofibrate) Tablets, 120 mg, 7 Count Bottles, Rx only, Physician Samples… Failed Dissolution Specifications; 3-month stability |
FDA record score
0 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
9 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Inspection classified VAI | Feb 2, 2015 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | May 16, 2013 | 10 years or older, so it adds no points | 0 |
| Class II recall D-1398-2012, this FEI as the recalling firm | Mar 8, 2012 | 10 years or older, so it adds no points | 0 |
| Class II recall D-210-2011, this FEI as the recalling firm | Dec 23, 2010 | 10 years or older, so it adds no points | 0 |
| Class II recall D-109-2011, this FEI as the recalling firm | Oct 28, 2010 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Jul 9, 2010 | 10 years or older, so it adds no points | 0 |
| Class II recall D-1889-2009, this FEI as the recalling firm | Aug 3, 2009 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Jan 15, 2009 | 10 years or older, so it adds no points | 0 |
| Class II recall D-042-2009, this FEI as the recalling firm | Jul 11, 2008 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Inspection citations | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
| Warning letter text | Nov 16, 2026 | Newest record Nov 10, 2026 | Current |
| Recalls (Enforcement Report) | Nov 16, 2026 | Newest record Nov 11, 2026 | Current |
| Form 483s and inspection documents | Nov 13, 2026 | Newest record Nov 12, 2026 | Current |
| Import refusals | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
Reviewing Shionogi Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Shionogi Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- Shionogi Inc.
- Location
- Alpharetta, GA (US)
- Source
- inspections